CAMBRIDGE, Mass., Oct. 26, 2007 (PRIME NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced it will be making presentations at two upcoming healthcare conferences.
